MINNESOTA: They won’t say who, but the American Cannabis Company is counseling a group of “Minnesota-based entrepreneurs” who want to become manufacturers of the new state-sanctioned medicine.
ACC got off the ground last year in Colorado, working with local applicants, but has since expanded to include clients across the U.S. and as far as the eastern seaboard of Canada. Trent Woloveck, the company COO, says his team will be tasked with meeting Minnesota regulatory standards while “bringing what our best practices are from these more mature markets.”
The details are still murky, but they won’t be for long. The public will get a good look at the challenges facing certified medical cannabis manufacturers on Aug. 8. A meeting is schedule to begin at 10 a.m. in the Skjegstad Room of the Minnesota Department of Revenue Building, located at 600 Robert Street North, St. Paul. (RSVP with an organizer.)
A draft request for manufacturers is due out in August, and the state expects to pick two firms by December (as determined by law) who will stock eight dispensaries. Patients with qualifying conditions are supposed to begin receiving non-leafy forms of cannabis by July 1 2015 — a date that could be pushed back six months if the state feels it isn’t ready.